ストックスクリーナーアプリを入手
1.93
3.98%
-0.08
アフターアワーズ：
1.96
0.03
+1.55%
前日終値:
$2.01
開ける：
$1.97
24時間の取引高:
748.02K
Relative Volume:
0.51
時価総額：
$320.38M
収益：
$137.74M
当期純損益:
$-27.97M
株価収益率:
-12.06
EPS:
-0.16
ネットキャッシュフロー:
$-9.61M
1週間 パフォーマンス:
-8.10%
1か月 パフォーマンス:
+4.89%
6か月 パフォーマンス:
+20.62%
1年 パフォーマンス:
-46.91%
1日の値動き範囲:
$1.92
$2.00
1週間の範囲:
$1.92
$2.209
52週間の値動き範囲:
$1.04
$3.73
Heron Therapeutics Inc Stock (HRTX) Company Profile
名前
Heron Therapeutics Inc
セクター
電話
(858) 251-4400
住所
4242 CAMPUS POINT COURT, SUITE 200, SAN DIEGO, CA
HRTX を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
HRTX
Heron Therapeutics Inc
|
1.93 | 320.38M | 137.74M | -27.97M | -9.61M | -0.16 |
|
VRTX
Vertex Pharmaceuticals Inc
|
455.45 | 115.69B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
529.24 | 53.25B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
307.99 | 39.22B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
577.89 | 35.78B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
269.63 | 27.68B | 3.81B | -644.79M | -669.77M | -6.24 |
Heron Therapeutics Inc Stock (HRTX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-06-09 | 開始されました | H.C. Wainwright | Buy |
| 2024-06-13 | 開始されました | Rodman & Renshaw | Buy |
| 2024-04-23 | 開始されました | CapitalOne | Overweight |
| 2024-03-13 | 繰り返されました | Needham | Buy |
| 2020-05-27 | 開始されました | Guggenheim | Buy |
| 2020-02-20 | 繰り返されました | Needham | Buy |
| 2019-01-16 | 繰り返されました | Needham | Buy |
| 2018-04-05 | 開始されました | Evercore ISI | Outperform |
| 2018-03-19 | 繰り返されました | Mizuho | Buy |
| 2018-03-01 | 繰り返されました | Needham | Buy |
| 2018-01-03 | 開始されました | Leerink Partners | Outperform |
| 2017-09-27 | 開始されました | Northland Capital | Outperform |
| 2017-02-27 | 開始されました | Needham | Buy |
| 2016-10-26 | 開始されました | Aegis Capital | Buy |
| 2016-09-06 | 再開されました | Lake Street | Buy |
| 2016-05-03 | 開始されました | Cantor Fitzgerald | Buy |
| 2015-12-10 | 開始されました | Lake Street | Buy |
| 2015-09-23 | 繰り返されました | Leerink Partners | Outperform |
| 2015-09-02 | 開始されました | BofA/Merrill | Buy |
| 2015-08-03 | 繰り返されました | Brean Capital | Buy |
| 2015-06-30 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2015-06-19 | 繰り返されました | Leerink Partners | Outperform |
| 2014-08-07 | 開始されました | Noble Financial | Buy |
すべてを表示
Heron Therapeutics Inc (HRTX) 最新ニュース
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by Millennium Management LLC - MarketBeat
What is HC Wainwright's Forecast for HRTX Q2 Earnings? - MarketBeat
Jane Street Group LLC Sells 284,299 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Coverage Initiated by Analysts at HC Wainwright - MarketBeat
Q2 Earnings Forecast for HRTX Issued By HC Wainwright - Defense World
Heron Therapeutics (NASDAQ:HRTX) Now Covered by Analysts at HC Wainwright - Defense World
Heron Therapeutics (HRTX) Receives "Buy" Initiation from HC Wainwright | HRTX Stock News - GuruFocus
HC Wainwright Initiates Coverage on Heron Therapeutics With Buy Rating, $6 Price Target - marketscreener.com
Heron Therapeutics (HRTX) Gains Buy Rating and Positive Outlook | HRTX Stock News - GuruFocus
Heron Therapeutics (NASDAQ:HRTX) Upgraded to "Buy" at Wall Street Zen - MarketBeat
Nuveen Asset Management LLC Sells 792,421 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Wellington Management Group LLP Sells 8,105 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Wall Street Zen Upgrades Heron Therapeutics (NASDAQ:HRTX) to “Buy” - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Lessened by Two Sigma Investments LP - MarketBeat
Nuveen Asset Management LLC Reduces Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stake Raised by Bank of America Corp DE - Defense World
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Bought by ProShare Advisors LLC - Defense World
Two Sigma Investments LP Sells 411,906 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Heron Therapeutics, Inc. To Contact The Firm - ACCESS Newswire
Northern Trust Corp Buys 21,769 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (NASDAQ:HRTX) Stock Rating Lowered by Wall Street Zen - MarketBeat
3,075,809 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Bought by Point72 Asset Management L.P. - MarketBeat
20,000 Shares in Heron Therapeutics, Inc. (NASDAQ:HRTX) Purchased by Focus Partners Wealth - Defense World
Tang Capital Management LLC Purchases 290,271 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Stonepine Capital Management LLC Buys Shares of 700,000 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
D. E. Shaw & Co. Inc. Trims Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Q&A with Barry Quart, CEO at Connect Biopharma - citybiz
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Purchased by Price T Rowe Associates Inc. MD - Defense World
Raymond James Financial Inc. Buys New Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Bridgeway Capital Management LLC Acquires Shares of 300,000 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Volatility Of Heron Therapeutics Inc (HRTX) Reaches 9.24%: Make Sure To Keep Your Seat Tight! - Stocksregister
J. Goldman & Co LP Acquires Shares of 270,100 Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
What is Northland Capmk's Estimate for HRTX Q2 Earnings? - MarketBeat
Clearline Capital LP Has $2.77 Million Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Raymond James Financial Inc. Buys Shares of 135,722 Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Wells Fargo & Company MN Has $114,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (NASDAQ:HRTX) Posts Quarterly Earnings Results, Beats Estimates By $0.02 EPS - MarketBeat
Heron Therapeutics Sees Unusually Large Options Volume (NASDAQ:HRTX) - MarketBeat
Barclays PLC Grows Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics Inc (HRTX) 財務データ
収益
当期純利益
現金流量
EPS
1.91%
1.17%
大文字化:
|
ボリューム (24 時間):